Article Sidebar

PDF
Date Published: 15/11/2023
Abstract Views: 262
Views PDF: 108
DOI: https://doi.org/10.51298/vmj.v531i2.7166
Issue
Vol. 531 No. 2 (2023)
Section
Các bài báo
How to Cite
Dương , T. T. T. ., Bùi , T. B. ., & Tạ , V. T. (2023). RESEARCH IDENTIFIED SOME GENE MUTATIONS THAT CAUSE HYPERTENSION BY SANGER GENE SEQUENCING METHOD. Vietnam Medical Journal, 531(2). https://doi.org/10.51298/vmj.v531i2.7166

RESEARCH IDENTIFIED SOME GENE MUTATIONS THAT CAUSE HYPERTENSION BY SANGER GENE SEQUENCING METHOD

Thị Thùy Trang Dương 1, Thị Bảo Bùi , Văn Thạo Tạ 1,
1 HMU

Main Article Content

Abstract

Hypertension (HTN) is one of the biggest issues for global public health today, not only for development countries but also for developing countries, especially HTN is getting younger and younger. With unpredictable complications, hypertension increases the mortality rate, increases the rate of disability and affects the patient's life. In which, up to 95% is due to idiopathic hypertension. This study aims to identify some single nucleotide polymorphisms (SNPs) that cause the risk of idiopathic hypertension. Objectives: Study of 4 SNPs with the highest frequency of variants on the CYP3A, NOS3 and GNB3 genes, including the CYP3A5 – 6096A-G (c.7081 A>G); NOS3 – E298D (c.8007 T>G); NOS3-786T-C (c.1975 C>T) and GNB3-825C-T (c.4787 C>T) by Sanger sequencing. Samples of 5 patients with hypertension of unknown cause are used in this study. Methods: A cross-sectional descriptive study. Results: The CYP3A5 – 6096A-G with homozygous genotype was detected in all 5 patients. The NOS3 – E298D (c.8007 T>G) SNP was identified in 3 patients with  homozygous genotype and 1 patient with homozygous genotype. The NOS3-786T-C was found in all 5 patients with rate of 4:1 (homozygous:heterozygous). The result also indicated 3 patients with  heterozygous genotype and 1 patient with homozygous genotype of GNB3-825C-T SNP.

Article Details

Keywords

Hypertension, CYP3A5, NOS3, GNB3

References

1. Zhou B, Carrillo-Larco RM, Danaei G, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. The Lancet. 2021;398(10304):957-980. doi:10.1016/S0140-6736(21)01330-1
2. Minh HV, Poulter NR, Viet NL, et al. Blood pressure screening results from May Measurement Month 2019 in Vietnam. Eur Heart J Suppl. 2021; 23 (Suppl B): B154-B157. doi: 10.1093/eurheartj/ suab035
3. Givens RC, Lin YS, Dowling ALS, et al. CYP3A5 genotype predicts renal CYP3A activity and blood pressure in healthy adults. J Appl Physiol (1985). 2003; 95(3): 1297-1300. doi: 10.1152/ japplphysiol.00322.2003
4. Sử HX. Khảo sát mối liên quan liều, nồng độ tacrolimus, mức lọc cầu thận với đa hình kiểu gen CYP3A5 ở người bệnh ghép thận. Journal of 108 - Clinical Medicine and Phamarcy. Published online February 9, 2023. doi:10.52389/ydls.v18i1.1629
5. Seyedrezazadeh E, Faramarzi E, Bakhtiyari N, et al. Association of NOS3-c.894G>T transversion with susceptibility to metabolic syndrome in Azar-cohort population: A case-control study and in silico analysis of the molecular effects. Iran J Basic Med Sci. 2021; 24(3): 408-419. doi: 10.22038/ ijbms. 2021. 50528. 11511
6. Hyndman ME, Parsons HG, Verma S, et al. The T-786-->C mutation in endothelial nitric oxide synthase is associated with hypertension. Hypertension. 2002;39(4):919-922. doi: 10.1161/ 01.hyp. 0000013703. 07316.7f
7. El Din Hemimi NS, Mansour AA, Abdelsalam MM. Prediction of the Risk for Essential Hypertension among Carriers of C825T Genetic Polymorphism of G Protein β3 (GNB3) Gene. Biomark Insights. 2016; 11:69-75. doi: 10.4137/ BMI.S38321